Skip to content

External Quality Assessment for Genomics & Molecular Pathology

Support the quality of your molecular oncology testing with clinically relevant EQA schemes designed for NGS-based cancer panel testing and other molecular methods for the detection and interpretation of somatic variants.

Why Choose Labquality's Genomics & Molecular Pathology EQA?

Our Genomics & Molecular Pathology EQA schemes help laboratories assess and improve the quality of variant detection, interpretation and reporting using clinically relevant sample materials. Developed with genomics experts, the programme combines clinically relevant materials, comprehensive assessment and efficient electronic reporting to support high-quality molecular oncology testing.

icon_purple_dna

Clinically relevant sample materials

Assess laboratory performance using carefully selected FFPE sample materials that reflect real-world molecular oncology testing. 

icon_purple_näytteenotto

Designed for molecular oncology laboratories

Suitable for laboratories performing NGS-based cancer panel testing and other molecular methods for the detection and interpretation of somatic variants.

icon_purple_EQA_2

Comprehensive performance assessment

Assess the quality of variant detection, interpretation and reporting to identify opportunities for quality improvement.

icon_purple_check_round

Supports quality improvement and accreditation

Demonstrate the quality of your molecular testing and support continuous improvement and accreditation activities. 

icon_purple_scientist

Developed with genomics experts

Designed in collaboration with experienced genomics and molecular pathology professionals to ensure scientific relevance and practical value. 

icon-purple-lightning

Efficient online reporting

Submit results and access reports through LabScala, Labquality's secure electronic reporting platform designed for efficient EQA participation.

Why participate in EQA?

Participation helps laboratories:

  • assess laboratory performance using clinically relevant materials
  • evaluate variant detection, interpretation and reporting
  • identify opportunities for quality improvement
  • support accreditation and continuous quality management
  • benchmark performance against peer laboratories

Trusted expertise in external quality assessment

Built on Labquality's decades of experience in external quality assessment, the Genomics & Molecular Pathology programme combines scientific expertise with clinically relevant sample materials and practical electronic reporting to support reliable molecular diagnostics.

About the programme

Labquality's Genomics & Molecular Pathology EQA programme is designed for laboratories performing molecular oncology testing using next-generation sequencing (NGS), targeted cancer panels and other molecular methods for analysing somatic variants in cancer samples.

The programme currently includes four oncology-specific EQA schemes for FFPE-based cancer panel testing. The programme will continue to expand with new EQA schemes and pilot rounds, including schemes based on cfDNA sample materials, to support the evolving needs of molecular diagnostics laboratories.

Available EQA schemes

NGS in Clinical Oncology – Pan Cancer

FFPE-based cancer panel testing. Product number: 6810

April 2027

NGS in Clinical Oncology - Breast Cancer

FFPE-based cancer panel testing. Product number: 6811

May 2027

NGS in Clinical Oncology - Colon Cancer

FFPE-based cancer panel testing. Product number: 6812

June 2027

NGS in Clinical Oncology - Lung Cancer

FFPE-based cancer panel testing. Product number: 6813

June 2027

Ready to strengthen your laboratory's quality in molecular oncology testing?

Explore the available Genomics & Molecular Pathology EQA schemes or contact our experts to discuss which programme best suits your laboratory.

Contact us to discuss which programme best fits your laboratory!

Kevin Shami
Kevin Shami
Genomics Portfolio Consultant
Heidi Berghäll
Heidi Berghäll
EQA Solutions Director